(Q36678424)

15 August 2017

1 reference

title

Prognostic significance of proteolytic enzymes in human brain tumors (English)

1 reference

15 August 2017

1 reference

Bindal AK

1

1 reference

15 August 2017

Hammoud M

2

1 reference

15 August 2017

Shi WM

3

1 reference

15 August 2017

Wu SZ

4

1 reference

15 August 2017

Sawaya R

5

1 reference

15 August 2017

Rao JS

6

1 reference

15 August 2017

publication date

1 January 1994

1 reference

Journal of Neuro-Oncology

15 August 2017

published in

1 reference

15 August 2017

volume

22

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

101-110

1 reference

Immunohistochemical localisation of tissue plasminogen activator in human brain tumours

15 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01052886

Antibodies to plasminogen activator inhibit human tumor metastasis

21 January 2018

1 reference

12 December 2020

Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain.

1 reference

12 December 2020

Distribution of extracellular matrix proteins in primary human brain tumours: an immunohistochemical analysis.

1 reference

12 December 2020

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor

1 reference

12 December 2020

Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme

1 reference

12 December 2020

Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo.

1 reference

12 December 2020

Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma.

1 reference

12 December 2020

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer

1 reference

12 December 2020

The morphology of hemostasis failure in gliosal brain tumors

1 reference

12 December 2020

Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo

1 reference

12 December 2020

Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo

1 reference

12 December 2020

Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo

1 reference

12 December 2020

The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma

1 reference

12 December 2020

Is necrosis helpful in the grading of gliomas? Editorial opinion

1 reference

12 December 2020

Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma

1 reference

12 December 2020

Pathological changes in blood vessels of human glioblastoma multiforme. Comparative studies using plastic casting, angiography, light microscopy and electron microscopy, and with reference to some other brain tumours

1 reference

12 December 2020

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

12 December 2020

Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.

1 reference

12 December 2020

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

1 reference

12 December 2020

Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.

1 reference

12 December 2020

Plasminogen Activation by Receptor-Bound Urokinase

1 reference

12 December 2020

Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors

1 reference

12 December 2020

Capillary Ultrastructure and the Blood-Brain Barrier in Human Malignant Brain Tumors

1 reference

12 December 2020

Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas

1 reference

12 December 2020

Correlation of tumor plasminogen activator with peritumoral cerebral edema. A CT and biochemical study.

1 reference

12 December 2020

Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro

1 reference

12 December 2020

Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis

1 reference

12 December 2020

Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor

1 reference

12 December 2020

Glucocorticoids inhibit plasminogen activator production by endothelial cells

1 reference

12 December 2020

Biological significance of tissue plasminogen activator content in brain tumors

1 reference

12 December 2020

Plasminogen activator inhibitor-1 in brain tumors: relation to malignancy and necrosis

1 reference

12 December 2020

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue

1 reference

12 December 2020

Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cells

1 reference

12 December 2020

Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells

1 reference

12 December 2020

The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: Cerebral exposure to bradykinin and plasma

1 reference

12 December 2020

Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes

1 reference

12 December 2020

Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells

1 reference

12 December 2020

Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors.

1 reference

12 December 2020

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

1 reference

12 December 2020

Type-1 plasminogen activator inhibitor in human breast carcinomas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01052886

1 reference

15 August 2017

1 reference